Search details
1.
Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.
Proc Natl Acad Sci U S A
; 117(51): 32370-32379, 2020 12 22.
Article
in English
| MEDLINE | ID: mdl-33288723
2.
Heteroleptic Pd(II) and Pt(II) Complexes with Redox-Active Ligands: Synthesis, Structure, and Multimodal Anticancer Mechanism.
Inorg Chem
; 61(4): 2105-2118, 2022 Jan 31.
Article
in English
| MEDLINE | ID: mdl-35029379
3.
Bulge-Forming miRNases Cleave Oncogenic miRNAs at the Central Loop Region in a Sequence-Specific Manner.
Int J Mol Sci
; 23(12)2022 Jun 12.
Article
in English
| MEDLINE | ID: mdl-35743015
4.
Site-Selective Artificial Ribonucleases: Renaissance of Oligonucleotide Conjugates for Irreversible Cleavage of RNA Sequences.
Molecules
; 26(6)2021 Mar 19.
Article
in English
| MEDLINE | ID: mdl-33808835
5.
Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance.
Molecules
; 25(10)2020 May 25.
Article
in English
| MEDLINE | ID: mdl-32466298
6.
Transport Oligonucleotides-A Novel System for Intracellular Delivery of Antisense Therapeutics.
Molecules
; 25(16)2020 Aug 11.
Article
in English
| MEDLINE | ID: mdl-32796768
7.
Tribute to Sidney Altman.
RNA
; 28(11): 1393-1429, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36113877
8.
Engineering supramolecular dynamics of self-assembly and turnover of oncogenic microRNAs to drive their synergistic destruction in tumor models.
Biomaterials
; 309: 122604, 2024 May 06.
Article
in English
| MEDLINE | ID: mdl-38733658
9.
Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy.
Cancers (Basel)
; 14(18)2022 Sep 09.
Article
in English
| MEDLINE | ID: mdl-36139555
10.
Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells.
Mol Ther Nucleic Acids
; 27: 211-226, 2022 Mar 08.
Article
in English
| MEDLINE | ID: mdl-34976439
11.
The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy.
BMC Cancer
; 10: 204, 2010 May 14.
Article
in English
| MEDLINE | ID: mdl-20470373
12.
Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics.
Front Pharmacol
; 10: 488, 2019.
Article
in English
| MEDLINE | ID: mdl-31156429
13.
Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model.
Front Pharmacol
; 10: 879, 2019.
Article
in English
| MEDLINE | ID: mdl-31456683
14.
The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy.
Oncotarget
; 8(45): 78796-78810, 2017 Oct 03.
Article
in English
| MEDLINE | ID: mdl-29108266
15.
Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment.
PLoS One
; 12(2): e0171988, 2017.
Article
in English
| MEDLINE | ID: mdl-28222152
16.
miRNases: Novel peptide-oligonucleotide bioconjugates that silence miR-21 in lymphosarcoma cells.
Biomaterials
; 122: 163-178, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28126663
17.
MicroRNA drop in the bloodstream and microRNA boost in the tumour caused by treatment with ribonuclease A leads to an attenuation of tumour malignancy.
PLoS One
; 8(12): e83482, 2013.
Article
in English
| MEDLINE | ID: mdl-24386211
18.
Ribonuclease binase inhibits primary tumor growth and metastases via apoptosis induction in tumor cells.
Cell Cycle
; 12(13): 2120-31, 2013 Jul 01.
Article
in English
| MEDLINE | ID: mdl-23759588
19.
The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma.
ISRN Oncol
; 2012: 721612, 2012.
Article
in English
| MEDLINE | ID: mdl-23251817
20.
Inhibition of metastasis development by daily administration of ultralow doses of RNase A and DNase I.
Biochimie
; 93(4): 689-96, 2011 Apr.
Article
in English
| MEDLINE | ID: mdl-21194552
Results
1 -
20
de 20
1
Next >
>>